"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insu
This observational study examines whether sexual activity influences the risk of hypoglycemia in adults with type 1 or type 2 diabetes treated with insulin therapy and using continuous glucose monitoring (CGM). Many patients report fear of hypoglycemia during or after sexual activity, which may affect their quality of
| Condition(s) | Type 1 Diabetes (T1D), Type 2 Diabetes (T2DM), Hypoglycemia |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This observational study examines whether sexual activity influences the risk of hypoglycemia in adults with type 1 or type 2 diabetes treated with insulin therapy and using continuous glucose monitoring (CGM). Many patients report fear of hypoglycemia during or after sexual activity, which may affect their quality of life and willingness to engage in intimate relationships. However, no systematic research has been conducted on this topic, largely due to the sensitive nature of sexual health and the previous lack of tools to remotely monitor glucose profiles. The study uses CGM systems (LibreView or Dexcom Clarity) to evaluate glucose changes during and up to 6 hours after sexual activity. Participants will mark the start of sexual activity in their CGM application using a neutral symbol ( |
| Who can participate | Inclusion Criteria: * Adults aged ≥18 years. * Diagnosis of type 1 or type 2 diabetes. * Current use of a continuous glucose monitoring (CGM) system. * Treatment with insulin therapy in any regimen. * Ability to operate the CGM application and mark the start of sexual activity. * Willingness to participate for 3 months. * Signed informed consent. Exclusion Criteria: * Inability to independently use the CGM application. * No sexual activity during the study period. * Withdrawal of consent at any time. * Any condition that, in the opinion of the investigator, prevents safe participation. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Medical University of Warsaw |
| Locations | Warsaw, Poland |
| Start date | 2025-07-30 |
| NCT ID | NCT07286500 |
| Official listing | https://clinicaltrials.gov/study/NCT07286500 |